Follow @keithspeights
Recent articles
Better Coronavirus Stock: Gilead Sciences vs. Moderna
Both biotechs could be winners in fighting COVID-19, but which is more likely to be the bigger winner for investors?
3 Dividend Aristocrats to Buy and Hold Forever
Common denominators for these three stocks include great dividend records and solid businesses.
Got $3,000? 3 Game-Changing Stocks to Buy Right Now
They're making big differences in their respective markets and providing big gains for investors.
Why Exact Sciences Stock Skyrocketed Today
Investors liked the company's preliminary liquid biopsy data.
Rite Aid's Q2 Results Were Great, but Its Full-Year Guidance Wasn't
The pharmacy chain operator's good news wasn't enough to outweigh Wall Street's worries about its bottom-line outlook.
Why Owens & Minor Stock Skyrocketed 55% Today
Investors are excited about the company's revised full-year earnings guidance.
4 Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On
Are any of these stocks good bets for other investors?
3 Stocks That Could Double Your Money
And they could do it relatively soon.
Why Canopy Growth Stock Is Sliding Today
The most likely reason: poor financial results from a top rival.
Is This Hot IPO Stock a Better Buy Than Teladoc Health?
Amwell and Teladoc have a lot in common, but their differences matter most.
The Scariest Number in Aurora Cannabis' Q4 Results
It doesn't bode well for the Canadian cannabis producer's hopes of turning things around.
Why Wave Life Sciences Shares Vaulted Higher Today
Investors liked an analyst's upgrade of the biotech stock.
Why Cresco Labs Stock Jumped Today
The company received approval for its tenth cannabis dispensary in Illinois.
Why Aurora Cannabis Stock Is Flying High Today
An analyst's upgrade and hopes that better days are on the way are driving the pot stock higher.
Is Illumina Making an $8 Billion Blunder?
A lot of investors hate Illumina's planned acquisition of GRAIL. But is the deal really that bad?
Why Pfizer's Latest Big Win Makes It an Even Better Buy for Retirees
The big drugmaker could soon up its game in the lung cancer market.
3 Critical Catalysts on the Way for Inovio
With three important milestones just ahead, the biotech stock will likely soar or sink in the near future.
Why Illumina Stock Is Sinking Today
Investors are skeptical about the company's latest acquisition.
If You Invested $5,000 in Moderna in January, This Is How Much You'd Have Now
The biotech stock has been a big winner so far this year. And it could be an even bigger winner very soon.
Warren Buffett's 3 Best-Performing Stocks So Far This Year: Are They Buys Now?
These Buffett stocks have all delivered sizzling year-to-date gains. Can they keep the momentum going?